2010
DOI: 10.1093/jac/dkq485
|View full text |Cite
|
Sign up to set email alerts
|

Molecular characterization and phylogenetic analysis of quinolone resistance-determining regions (QRDRs) of gyrA, gyrB, parC and parE gene loci in viridans group streptococci isolated from adult patients with cystic fibrosis

Abstract: Treatment of P. aeruginosa with oral ciprofloxacin in patients with CF may concurrently reduce antibiotic susceptibility in the commensal VGS flora, where these organisms may potentially act as a reservoir of fluoroquinolone resistance gene determinants for newly acquired and antibiotic-susceptible pathogens, particularly the Streptococcus milleri group.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

3
27
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 35 publications
(30 citation statements)
references
References 20 publications
3
27
0
Order By: Relevance
“…3, we offer a workflow for VGS species identification that can be used in either a research or clinical setting. Importantly, although gyrB encodes part of DNA gyrase, which is a target of fluoroquinolones, polymorphisms in GyrB are not a major mechanism by which VGS strains develop fluoroquinolone resistance (32,36). Therefore, fluoroquinolone resistance does not influence the ability of GyrB to assign VGS strains to a particular species.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…3, we offer a workflow for VGS species identification that can be used in either a research or clinical setting. Importantly, although gyrB encodes part of DNA gyrase, which is a target of fluoroquinolones, polymorphisms in GyrB are not a major mechanism by which VGS strains develop fluoroquinolone resistance (32,36). Therefore, fluoroquinolone resistance does not influence the ability of GyrB to assign VGS strains to a particular species.…”
Section: Discussionmentioning
confidence: 99%
“…The sodA sequence used for phylogenetic analysis was the same sequence fragment used for MLSA (base pairs 46 to 423), as described previously (3). Amplification and sequencing of the gyrB fragment for each of the VGS strains were done using previously published primers and the protocol of Maeda et al (36). The region of gyrB used for phylogenetic analyses and species identification was nucleotides 1113 to 1512, corresponding to amino acids 371 to 503.…”
Section: Methodsmentioning
confidence: 99%
“…Antimicrobial susceptibility was tested by the disk diffusion method according to the Clinical and Laboratory Standards Institute guidelines, and MICs of ciprofloxacin, norfloxacin, cefotaxime, ceftriaxone, and nalidixic acid were determined by Etest strips (AB Biodisk, Solna, Sweden); E. coli ATCC 25922 was used as the quality control organism. Resistance genes gyrA, gyrB, parC, parE, qnr, acc, bla TEM , and bla CTX-M were detected using previously described PCR methods (4,5,8). Bidirectional sequence data were obtained for these resistance and virulence genes.…”
mentioning
confidence: 99%
“…In recent decades, an increasing number of E. coli isolates have acquired resistance to quinolones or extended-spectrum cephalosporins (5,13). However, few studies have described E. coli isolates that simultaneously display resistance to these two antimicrobials, which was primarily due to several ESBL-producing resistant genes (3,8). In contrast, the E. coli isolates in this study carried more resistant genes [i.e., two mutations in gyrA (Ser83¡Leu, Asp87¡Asn), two in parC (Ser80¡Ile, Ala108¡Val), one in parE (Ser458¡Ala), and aac(6=)-Ib-cr and bla CTX-M-15 ], which led to high-level resistance to both quinolones and extended-spectrum cephalosporins.…”
mentioning
confidence: 99%
“…The QRDRs, gyrA, gyrB, parC and parE gene loci, were analysed through sequence typing for all VGS isolates examined (Maeda et al, 2011), as well as carrying out detection and characterization of the macrolide resistance determinants, the ermB and mefA/E gene loci (Tazumi et al, 2009). These methods employed the sequencing of known gene resistance determinants associated with macrolide resistance, as well as fluoroquinolone resistance.…”
Section: Methodsmentioning
confidence: 99%